Navigation Links
Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
Date:9/25/2008

Express Atom Stent significantly reduced the chance of restenosis and the need for repeat procedures compared to bare-metal stents, in patients with small vessel disease."

"Our TAXUS Express Atom Stent addresses an unmet need and will help interventional cardiologists better treat small vessel disease," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "With the recent FDA approval of our PROMUS(TM) Stent and now the TAXUS Express Atom Stent for small vessels, Boston Scientific offers the most comprehensive DES portfolio in the industry, offering physicians and their patients the broadest size matrix and the industry's only two-drug platform."

"In addition to being a welcome product approval, we believe this is also an important indication we have made significant progress toward resolving the issues related to the Corporate Warning Letter," added Tobin.

TAXUS stents have been evaluated by the industry's most extensive randomized, controlled clinical trial program, with follow-up to five years in some cases. These trial results have been supplemented by data on more than 35,000 patients enrolled in post-approval registries. To date, approximately 4.6 million TAXUS stents have been implanted globally, making them the world's most frequently used drug-eluting stents.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These fo
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific to Participate in UBS Global Life Sciences Conference
2. Boston Scientific Announces Court Decision
3. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
4. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
5. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
6. TechCFO Adds Gary Strickland as Partner in Boston Office
7. Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
8. Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
9. Boston Scientific Welcomes Revised Outlook From Fitch Ratings
10. Boston Scientific to Participate in Goldman Sachs Conference
11. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  AsureQuality and Ubiquitome have agreed ... applications in food and primary production sectors. The ... PCR device, the Freedom4. AsureQuality provides ... the supermarket shelf for producers, processors and Competent ... animal disease control and pest management and surveillance ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)...  AmnioChor Inc., an early stage biotech startup based ... announce that the Musculoskeletal Transplant Foundation of ... their seed round of development of the proprietary AmnioCept™ ... AmnioChor,s technology allows cryopreservation of the amniotic ... living within those tissues. Amnion is a well-established source ...
(Date:7/29/2015)... DIEGO , July 29, 2015  Pfenex Inc. ... 2015 financial results will be released on Thursday, August ... am Eastern Time, Pfenex management will host a conference ... business update.  A press release outlining the financial results ... the call. Please call 1-866-376-8058 (US) or ...
Breaking Biology Technology:AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... FREDERICK, Md., Aug. 28 BioElectronics,Corporation, (Pink Sheets: ... a sales and distribution agreement to provide ActiPatch,Therapy ... order has been,shipped and introduction of ActiPatch to ... in the benefits of ActiPatch by the Healthcare ...
... AG (Frankfurt Stock Exchange: EVT) is pleased to invite you ... data for its,lead compound EVT 201 in the treatment of ... am GMT / 5.00 am EST / 7.00 pm AEST ... the webcast and,conference call will be: - Dr John ...
... Transfer its ADR Listing to the NASDAQ Capital ... Biopharmaceuticals,Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: ... and commercialization of,therapeutics for the treatment of unmet ... announced the receipt on August 23,2007, of a ...
Cached Biology Technology:BioElectronics Corporation Announces Singapore and Malaysia Sales 2Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia 2XTL Receives Staff Letter From NASDAQ 2XTL Receives Staff Letter From NASDAQ 3
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015  Synaptics ... interface solutions, announced today that it will report financial ... on Thursday, July 30, 2015 after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... Mass.--High oil prices, energy security considerations and fears about ... sources like biofuels, which burn cleanly and can be ... catches, particularly regarding biofuels like corn-based ethanol: the more ... available for fooda reality that partly accounts for the ...
... available in French. , Hunted to ... along the Pacific coast. Their reintroduction, however, is expected ... commercially valuable shellfish dramatically, such as sea urchins and ... Kai Chan, an NSERC-funded researcher at the University of ...
... The U.S. Department of Homeland,Security (DHS) ... additional,fingerprints from international visitors arriving at Orlando ... the department,s upgrade from two-,to 10-fingerprint collection ... more accurately and efficiently establishing and verifying,visitors, ...
Cached Biology News:MIT professor to discuss future of biofuels 2DHS Begins Collecting 10 Fingerprints From International Visitors at Orlando International Airport 2
b-Catenin (pSer675), phospho-specific...
MAb to Transferrin Dry Ice: No Preservative: NaN3 Availability When Not in Inventory: 14-21 Business Days...
Anti-ADAMTS-4, disintegrin-like domain Immunogen: Synthetic peptide - KLH conjugated Available Date: 38569...
WD-repeat protein 4...
Biology Products: